BioSpace News Archive

FDA

GENFIT announces FDA Grant of Breakthrough Therapy Designation to Elafibranor for the Treatment of PBC

FDA grants elafibranor Breakthrough Therapy Designation, based on Phase 2 data, for treatment of PBC (Primary Biliary Cholangitis) in adults with inadequate response to UDCA

April 18, 2019
·
7 min read
VAXIMM Announces Presentations at ASCO 2019 and Other Upcoming Industry and Scientific Events

VAXIMM AG announced that the Company will present an abstract about the design of its ongoing trial in patients with glioblastoma with VXM01 oral T-cell immunotherapy in combination with the anti-PD-L1 checkpoint inhibitor avelumab at the 2019 American Society of Clinical Oncology Annual Meeting.

April 18, 2019
·
2 min read
Deals

Lonza Announces Results of the 2019 Annual General Meeting – All Motions Proposed by Board of Directors Accepted

312 shareholders attended, representing 60% of the issued share capital

April 18, 2019
·
3 min read
Unique data-driven tool shows diabetes not a barrier to joint replacement surgery

Based on data from 40,000 patients, the ORA risk assessment tool is designed to support orthopaedic surgeons as they make decisions about joint replacement surgery.

April 18, 2019
·
3 min read
Deals

Evotec Completes Repayment Of Eur 140 M Acquisition Loan

Eur 140 m bridge loan was drawn to secure evotec’s value chain expansion by successful acquisition of aptuit in august 2017

April 18, 2019
·
3 min read
Business

Microbix Announces Management Changes

Ken Hughes Appointed COO, Kathryn Froh Retiring

April 18, 2019
·
4 min read